Dermot McGrath
EuroTimes articles by Dermot McGrath
-
The future of glaucoma diagnosis
Thursday, July 30, 2020Applying AI to glaucoma diagnosis and management
-
Treatment options for VMT
Thursday, July 30, 2020Pneumatic vitreolysis safe and effective in vitreomacular traction
-
Axial elongation in high myopia
Wednesday, July 29, 2020Axial elongation is the most important mechanism contributing to the development of myopic macular degeneration (MMD), with no clear evidence of molecular factors specifically associated with development of the condition
-
Surgery in exudative AMD
Wednesday, July 29, 2020In an era when intravitreal anti-VEGF is the mainstay of treatment in exudative age-related macular degeneration (AMD), vitreoretinal surgery still has a fundamental role to play in managing patients with advanced disease
-
COVID-19 crisis sparks growth in tele-ophthalmology
Tuesday, July 7, 2020With tele-ophthalmology already gaining traction in recent years as an effective eyecare delivery modality worldwide, the COVID-19 pandemic has served to further amplify this trend
-
Innovating in times of crisis
Tuesday, July 7, 2020Lessons learnt from New York in the COVID-19 pandemic
-
Longer acting drugs for retinal disease
Tuesday, June 30, 2020New slow-release drugs targeting a range of retinal diseases are currently finding their way into clinical practice and could herald a major change in the way patients are managed
-
New small aperture IOL
Monday, June 29, 2020Initial results of a new small-aperture IOL show that the lens offers high levels of safety and efficacy when implanted binocularly in cataract patients
-
Novel keratoconus biomarker
Sunday, June 28, 2020Progress is being made on several fronts to advance understanding of the complex pathogenesis of keratoconus, including identification of a novel biomarker that may prove useful as a supplemental diagnostic test for the disease,
-
Biomarkers in retinal disease
Saturday, June 6, 2020Initial trials of an automatic biomarker classifier show that it is capable of outperforming human experts in the task of biomarker detection in optical coherence tomography (OCT) scans, paving the way for more efficient and economical ocular disease screening and detection
